Shopping Cart
- Remove All
Your shopping cart is currently empty
Dalotuzumab
🥰Excellent
Catalog No. T76800Cas No. 1005389-60-5
Alias MK-0646, h7C10
Dalotuzumab (MK-0646) is a recombinant humanized IgG1 monoclonal antibody that specifically targets the insulin-like growth factor 1 receptor (IGF-1R). its mechanism of action involves the inhibition of IGF-mediated oncogenic signaling, which subsequently induces apoptosis and cell cycle arrest in tumor cells, and it has demonstrated enhanced antitumor efficacy when used in combination with other chemotherapeutic agents.
Dalotuzumab
Dalotuzumab
🥰Excellent
Purity: 95%
Catalog No. T76800Alias MK-0646, h7C10Cas No. 1005389-60-5
Dalotuzumab (MK-0646) is a recombinant humanized IgG1 monoclonal antibody that specifically targets the insulin-like growth factor 1 receptor (IGF-1R). its mechanism of action involves the inhibition of IGF-mediated oncogenic signaling, which subsequently induces apoptosis and cell cycle arrest in tumor cells, and it has demonstrated enhanced antitumor efficacy when used in combination with other chemotherapeutic agents.
| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 1 mg | $247 | In Stock | |
| 5 mg | $645 | In Stock | |
| 10 mg | $987 | In Stock | |
| 25 mg | $1,460 | In Stock | |
| 50 mg | $1,970 | In Stock |
Add to Cart
Add to Quotation
Bulk & Custom
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
View MoreBatch Information
Select Batch
Concentration:6.13 mg/mL
Purity:95%
Contact us for more batch information
Resource Download
Product Introduction
Bioactivity
Chemical Properties
| Description | Dalotuzumab (MK-0646) is a recombinant humanized IgG1 monoclonal antibody that specifically targets the insulin-like growth factor 1 receptor (IGF-1R). its mechanism of action involves the inhibition of IGF-mediated oncogenic signaling, which subsequently induces apoptosis and cell cycle arrest in tumor cells, and it has demonstrated enhanced antitumor efficacy when used in combination with other chemotherapeutic agents. |
| In vitro | Dalotuzumab (33 nM, 24 h) was used to treat IGF-1-induced MCF7 cells, and the changes in cell cycle and the expression of IGF-IR and IRS-1 proteins were detected. Results: Dalotuzumab was able to induce cell cycle arrest in IGF-1-induced MCF7 cells and also inhibited the autophosphorylation of IGF-IR and IRS-1. [1] |
| In vivo | Methods: Dalotuzumab (MK-0646) (250 µg/mouse initially, then 125 µg/mouse, intraperitoneally twice a week for 40 days) was used to treat Swiss nude mice bearing MCF-7 and A549 xenograft tumors, and its tumor inhibition was observed. Results: Dalotuzumab reduced the average tumor volume of nude mice in the MCF-7 and A549 models by 70% and 72%, respectively. [1] |
| Synonyms | MK-0646, h7C10 |
| Molecular Weight | 146.4 (kDa) |
| Cas No. | 1005389-60-5 |
| Color | Transparent |
| Appearance | Liquid |
Storage & Solubility Information
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
In Vivo Formulation Calculator (Clear solution)
Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
For example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . A total of 10 animals were administered, and the formula you used is 5% 
DMSO+30% PEG300+5% Tween 80+60% Saline/PBS/ddH2O. So your working solution concentration is 2 mg/mL。Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSO (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
(mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.Preparation method for in vivo formula: Take 50 μL DMSO main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarify
main solution, add 300 μLPEG300 mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLSaline/PBS/ddH2O mix well and clarifyFor Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
Dose Conversion
You can also refer to dose conversion for different animals. More Dose Conversion
Sci Citations
Tech Support
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc
Preview
Related Tags: buy Dalotuzumab | purchase Dalotuzumab | Dalotuzumab cost | order Dalotuzumab | Dalotuzumab in vivo | Dalotuzumab in vitro | Dalotuzumab molecular weight
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.